SCHEDULE-DEPENDENT CYTO-TOXICITY OF METHOTREXATE AND 5-FLUOROURACIL IN HUMAN-COLON AND BREAST-TUMOR CELL-LINES

被引：67
|
作者：
BENZ, C
SCHOENBERG, M
CHOTI, M
CADMAN, E
机构：
[1] YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06510
[2] YALE UNIV,SCH MED,DEPT PHARMACOL,MED ONCOL SECT,NEW HAVEN,CT 06510
来源：
JOURNAL OF CLINICAL INVESTIGATION | 1980年 / 66卷 / 05期
关键词：
D O I：
10.1172/JCI109946
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1162 / 1165
页数：4
相关论文
共 50 条
  • [21] THE SELECTIVITY OF ACTION OF METHOTREXATE IN COMBINATION WITH 5-FLUOROURACIL IN XENOGRAFTS OF HUMAN-COLON ADENOCARCINOMAS
    HOUGHTON, JA
    TICE, AJ
    HOUGHTON, PJ
    MOLECULAR PHARMACOLOGY, 1982, 22 (03) : 771 - 778
  • [22] THE EFFECTS OF DIPYRIDAMOLE AND INDOMETHACIN ON METHOTREXATE CYTO-TOXICITY IN LOVO HUMAN-COLON CANCER-CELLS
    GAFFEN, JD
    CHAMBERS, EA
    BENNETT, A
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (05) : 350 - 352
  • [23] The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines
    Ojima, Eiki
    Inoue, Yasuhiro
    Watanabe, Hideki
    hiro, Junic Hiro
    Toiyama, Yuji
    Miki, Chikao
    Kusunoki, Masato
    ONCOLOGY REPORTS, 2006, 16 (05) : 1085 - 1091
  • [24] DIPYRIDAMOLE (DP) ENHANCEMENT OF FLUOROURACIL (FURA) CYTO-TOXICITY IN A HUMAN-COLON CANCER CELL-LINE (HCT 116)
    GREM, JL
    FISCHER, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 264 - 264
  • [25] Schedule-dependent synergism and antagonism between raltitrexed ("Tomudex") and methotrexate in human colon cancer cell lines in vitro
    Kano, Y
    Akutsu, M
    Tsunoda, S
    Suzuki, K
    Yazawa, Y
    Furukawa, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (01): : 74 - 82
  • [26] Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine
    Findenig, G
    Mader, RM
    FritzerSzekeres, M
    Steger, GG
    Jaeger, W
    Szekeres, T
    ONCOLOGY RESEARCH, 1996, 8 (05) : 189 - 196
  • [27] DIPYRIDAMOLE (DP) AUGMENTS THE CYTO-TOXICITY OF METHOTREXATE (MTX) AGAINST HUMAN-COLON CANCER-CELLS
    VANMOUWERIK, TJ
    PANGALLO, C
    WILLSON, JKV
    FISCHER, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 335 - 335
  • [28] Schedule-dependent synergistic effects of 5-fluorouracil and selumetinib in KRAS or BRAF mutant colon cancer models
    Jang, Hye Yeon
    Kim, Do Hyung
    Lee, Haeng Jung
    Kim, Won Dong
    Kim, Seog-Young
    Hwang, Jung Jin
    Lee, Seung Jin
    Moon, Dae Hyuk
    BIOCHEMICAL PHARMACOLOGY, 2019, 160 : 110 - 120
  • [29] NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER CYTO-TOXICITY OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES AGAINST 9 HUMAN-COLON CANCER CELL-LINES
    SOHN, SS
    CUNLIFFE, WJ
    OIE, HK
    SUGARBAKER, PH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 395 - 395
  • [30] METHOTREXATE INCREASES THE ACTIVATION AND CYTO-TOXICITY OF 5-FLUOROURACIL - DETECTED BY F-19 NMR INVIVO
    MCSHEEHY, PMJ
    PRIOR, MJW
    GRIFFITHS, JR
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (06) : 1050 - 1050
12345